ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SEPN vs ABBV // EV/EBITDA & P/E VALUATION

Septerna Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: SEPN 4 — ABBV 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SEPN VS. ABBV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SEPN ABBV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 70.20% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -20.70% 29.00% -49.70 ABBV /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 33.3x — TIE /valuation <GO>
Free Cash Flow Yield 5.19% 3.47% +1.72 SEPN /fcf-yield <GO>
Operating Margin -60.00% 24.60% -84.60 ABBV /operating-margins <GO>
Net Profit Margin -60.00% 6.90% -66.90 ABBV /net-margins <GO>
Revenue Growth (YoY) 180.00% 8.60% +171.40 SEPN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.27% -2.27 ABBV /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.87 5.33 +0.54 SEPN /balance-sheet <GO>
Piotroski F-Score Quality 6/9 7/9 -1.00 ABBV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 65.2 65.1 +0.06 SEPN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.15 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 113.1x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.11B $513.86B -$511.75B ABBV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SEPN REV ABBV REV SEPN GROSS % ABBV GROSS % SEPN FCF ABBV FCF
FY 2025 $46.0M $61.16B — 70.2% $109.7M $17.82B
FY 2024 $1.1M $56.33B — 70.0% -$69.6M $17.83B
FY 2023 $151.0K $54.32B — — -$38.7M $20.39B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SEPN // BETA —
ABBV // BETA 1.15